Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

NEOSPORIN Drug Profile

« Back to Dashboard

Which patents cover Neosporin, and what generic Neosporin alternatives are available?

Neosporin is a drug marketed by Casper Pharma Llc, Glaxosmithkline, and Monarch Pharms. and is included in four NDAs.

The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.

Summary for Tradename: NEOSPORIN

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list3
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEOSPORIN at DailyMed

Pharmacology for Tradename: NEOSPORIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc
NEOSPORIN
bacitracin zinc; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC050417-001Approved Prior to Jan 1, 1982ATRXYesNo► Subscribe► Subscribe
Monarch Pharms
NEOSPORIN G.U. IRRIGANT
neomycin sulfate; polymyxin b sulfate
SOLUTION;IRRIGATION060707-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe
Glaxosmithkline
NEOSPORIN
neomycin sulfate; polymyxin b sulfate
CREAM;TOPICAL050176-002Jan 14, 1985DISCNNoNo► Subscribe► Subscribe
Monarch Pharms
NEOSPORIN
gramicidin; neomycin sulfate; polymyxin b sulfate
SOLUTION/DROPS;OPHTHALMIC060582-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot